COVID-19 Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D1CS
|
|||
| Drug Name |
Boceprevir
|
|||
| Synonyms |
Victrelis; EBP 520; Sch 503034
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H45N5O5
|
|||
| Canonical SMILES |
CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C
|
|||
| InChI |
1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1
|
|||
| InChIKey |
LHHCSNFAOIFYRV-DOVBMPENSA-N
|
|||
| CAS Number |
CAS 394730-60-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:68621
|
|||
| Target | Top | |||
|---|---|---|---|---|
| Target(s) | COVID-19 3C-like protease (3CLpro) | Target Info | Inhibitor | [1] |
| The activity of boceprevir against the SARS-CoV-2 main protease (Mpro) has been successfully determined using the FRET-based enzymatic assay. | ||||
| References | Top | |||
|---|---|---|---|---|
| 1 | Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. 2020. April 20. doi: https://doi.org/10.1101/2020.04.20.051581 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.